The DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.
Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia—A Systematic Review and Meta-Analysis
Open accessAbstract
Background It is not known whether regional brain N-acetyl aspartate (NAA) changes in the progression from prodrome to chronic schizophrenia. We used effect size meta-analysis to determine which brain regions show the most robust reductions in NAA first episode and chronic schizophrenia as measured by proton magnetic resonance spectroscopy and to determine whether these changes are present in individuals at high risk of developing schizophrenia. Methods We identified 131 articles, of which 97 met inclusion criteria. Data were separated by stage of illness (at risk, first episode schizophrenia, chronic schizophrenia) and by brain region. For each region, mean and SD of the NAA measure was extracted. Results Significant reductions in NAA levels were found in frontal lobe, temporal lobe, and thalamus in both patient groups (effect size > .3; p < .01). In individuals at high risk of schizophrenia (of whom approximately 20% would be expected to undergo transition to psychosis), significant NAA reductions were present in thalamus (effect size = .78; p < .05), with reductions at trend level only in temporal lobe (effect size = .32; p < .1), and no reductions in frontal lobe (effect size = .05; p = .5). Conclusions These data suggest that schizophrenia is associated with loss of neuronal integrity in frontal and temporal cortices and in the thalamus and suggest that these changes in the frontal and temporal lobe might occur in the transition between the at-risk phase and the first episode.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although it is worth noting that changes in cortical glutamate levels may vary with the age and treatment history of the patients 67 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
MOFFETT, J., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.003 · Cited by 1,443
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., John Suckling, A., Phillips, L., Yung, A. R., Bullmore, E. T., Brewer, W. J., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,309
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
The Hippocampal Formation in Schizophrenia
Tamminga, C. A., Stan, A. D., & Wagner, A. D. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09081187 · Cited by 597
The Aging Hippocampus: Cognitive, Biochemical and Structural Findings
Driscoll, I. F. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg081 · Cited by 468
Théberge, J., Bartha, R., Drost, D., Menon, R. S., Malla, A., Takhar, J., Neufeld, R., Rogers, J., Pavlosky, W., Schaefer, B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1944 · Cited by 431
Declining Transition Rate in Ultra High Risk (Prodromal) Services: Dilution or Reduction of Risk?
Yung, A. R., Yuen, H. P., Berger, G. E., Francey, S. M., Hung, T.-C., Nelson, B., Phillips, L., & McGorry, P. D. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm015 · Cited by 422
Age at onset and cognition in schizophrenia: meta-analysis
Rajji, T. K., Ismail, Z., & Mulsant, B. H. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.060723 · Cited by 421
1H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites
Jansen, J. F. A., Backes, W. H., Nicolay, K., & Kooi, M. E. (2006) · Radiology · doi:10.1148/radiol.2402050314 · Cited by 414
Schobel, S., Lewandowski, N., Corcoran, C., Moore, H., Brown, T., Malaspina, D., & Small, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.115 · Cited by 384
Regional gray matter volume abnormalities in the at risk mental state.
Borgwardt, S., Riecher-Rössler, A., Dazzan, P., Chitnis, X., Aston, J., Drewe, M., Gschwandtner, U., Haller, S., Pflüger, M., Rechsteiner, E., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.009 · Cited by 329
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
Pilowsky, L. S., Bressan, R. A., Stone, J. M., Erlandsson, K., Mulligan, R. S., Krystal, J. H., & Ell, P. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001751 · Cited by 278
Self-citationAbnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania
Öngür, D., Jensen, J. E., Prescot, A. P., Stork, C., Lundy, M. Y., Cohen, B. M., & Renshaw, P. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.014 · Cited by 272
Théberge, J., Al-Semaan, Y. M., Williamson, P., Menon, R. S., Neufeld, R. W. J., Rajakumar, N., Schaefer, B., Densmore, M., & Drost, D. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2231 · Cited by 269
Bertolino, A., Nawroz, S., Mattay, V. S., Barnett, A. S., Duyn, J. H., MOONEN, C. T. W., Frank, J. A., Tedeschi, G., & Weinberger, D. R. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1554 · Cited by 256
Steen, R. G., Hamer, R. M., & Lieberman, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300850 · Cited by 254
Stone, J. M., Day, F., Tsagaraki, H., Valli, I., McLean, M. A., Lythgoe, D. J., O'Gorman, R. L., Barker, G. J., & McGuire, P. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.006 · Cited by 231
Bartha, R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220085012 · Cited by 230
Phillips, L., Yung, A., & McGorry, P. (2000) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1080/000486700239 · Cited by 207
Bertolino, A., Callicott, J. H., Elman, I., Mattay, V. S., Tedeschi, G., Frank, J. A., Breier, A. F., & Weinberger, D. R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00555-6 · Cited by 198
Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
Théberge, J., Williamson, K. E., Aoyama, N., Drost, D. J., Manchanda, R., Malla, A. K., Northcott, S., Menon, R. S., Neufeld, R. W. J., Rajakumar, N., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.033670 · Cited by 185
Bertolino, A., Breier, A., Callicott, J., Adler, C., Mattay, V., Shapiro, M., Frank, J., Pickar, D., & Weinberger, D. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00096-2 · Cited by 172
van Elst, L. T., Valerius, G., Büchert, M., Thiel, T., Rüsch, N., Bubl, E., Hennig, J., Ebert, D., & Olbrich, H. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.041 · Cited by 164
Bertolino, A., Callicott, J. H., Mattay, V. S., Weidenhammer, K. M., Rakow‐Penner, R., Egan, M. F., & Weinberger, D. R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00997-5 · Cited by 156
Tibbo, P. G., Hanstock, C. C., Valiakalayil, A., & Allen, P. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1116 · Cited by 152
Buckley, P. F., Moore, C. M., Long, H., Larkin, C., Thompson, P. A., Mulvany, F., Redmond, O., Stack, J. P., Ennis, J. T., & Waddington, J. L. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90591-6 · Cited by 152
Bertolino, A., Esposito, G., Callicott, J. H., Mattay, V. S., Horn, J. D. V., Frank, J. A., Berman, K. F., & Weinberger, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.26 · Cited by 149
Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients
Sharma, R. P., Venkatasubramanian, P. N., Bárány, M., & Davis, J. M. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90059-e · Cited by 148
Self-citationWhite Matter Alterations in Deficit Schizophrenia
Rowland, L. M., Spieker, E. A., Francis, A., Barker, P. B., Carpenter, W. T., & Buchanan, R. W. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.207 · Cited by 144
Keshavan, M. S., Montrose, D. M., Pierri, J. N., Dick, E. L., Rosenberg, D., Talagala, L., & Sweeney, J. A. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00164-4 · Cited by 143
Schuff, N. W., Amend, D. L., Knowlton, R. K., Norman, D. M., Fein, G., & Weiner, M. W. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00022-6 · Cited by 142
Steel, R. M., Bastin, M. E., McConnell, S., Marshall, I., Owens, D. G. C., Lawrie, S. M., Johnstone, E. C., & Best, J. J. K. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00080-4 · Cited by 138
Abbott, C., & Bustillo, J. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214337.29378.cd · Cited by 133
Callicott, J. H., Egan, M. F., Bertolino, A., Mattay, V. S., Langheim, F. J. P., Frank, J. A., & Weinberger, D. R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00264-9 · Cited by 131
Proton MRS in twin pairs discordant for schizophrenia
Lutkenhoff, E. S., van Erp, T. G., Thomas, M. A., Therman, S., Manninen, M., HUTTUNEN, M. O., Kaprio, J. A., Lönnqvist, J. K., O’Neill, J., & Cannon, T. D. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.87 · Cited by 127
Proton Magnetic Resonance Spectroscopy in First Episode Psychosis and Ultra High-Risk Individuals
Wood, S. J., Berger, G. E., Velakoulis, D., Phillips, L., McGorry, P. D., Yung, A. R., Desmond, P. M., & Pantelis, C. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007049 · Cited by 125
Proton Magnetic Resonance Spectroscopic Imaging of Cortical Gray and White Matter in Schizophrenia
Lim, K. O., Elfar Adalsteinsson, A., Spielman, D. M., Sullivan, E. V., Rosenbloom, M. J., & Pfefferbaum, A. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.346 · Cited by 122
Ohrmann, P., Siegmund, A., Suslow, T., Pedersen, A., Spitzberg, K., Kersting, A., Rothermundt, M., Arolt, V., Heindel, W., & Pfleiderer, B. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.002 · Cited by 116
Ende, G., Braus, D. F., Walter, S., Weber‐Fahr, W., Soher, B. J., Maudsley, A. A., & Henn, F. A. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00089-4 · Cited by 114
Altered Cortical Glutamate Neurotransmission in Schizophrenia
Lewis, D. A., Glantz, L. A., Pierri, J. N., & Sweet, R. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.007 · Cited by 113
Tayoshi, S., Sumitani, S., Taniguchi, K., Shibuya‐Tayoshi, S., Numata, S., Iga, J., Nakataki, M., Ueno, S., Harada, M., & Ohmori, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.11.014 · Cited by 111
Nasrallah, H. A., Skinner, T. E., Schmalbrock, P., & Robitaille, P.-M. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.165.4.481 · Cited by 108
Ohrmann, P., Siegmund, A., Suslow, T., Spitzberg, K., Kersting, A., Arolt, V., Heindel, W. L., & Pfleiderer, B. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.021 · Cited by 100
Olbrich, H. M., Valerius, G., Rüsch, N., Büchert, M., Thiel, T., Hennig, J., Ebert, D., & van Elst, L. T. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227811 · Cited by 96
Auer, D. P., Wilke, M., Grabner, A., Heidenreich, J. O., Bronisch, T., & Wetter, T. C. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00155-4 · Cited by 96
Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies
Kegeles, L. S., Shungu, D. C., Anjilvel, S., Chan, S. L., Ellis, S. P., Xanthopoulos, E. P., Malaspina, D., Gorman, J. M., Mann, J. J., Laruelle, M., et al. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(00)00044-5 · Cited by 87
Deicken, R. F., Zhou, L., Schuff, N. W., Fein, G., & Weiner, M. W. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00490-3 · Cited by 86
Fukuzako, H., Takeuchia, K., Hokazono, Y., Fukuzako, T., Yamada, K., Hashiguchi, T., Obo, Y., Ueyama, K., Takigawa, M., & Fujimoto, T. (1995) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(95)02622-5 · Cited by 85
Choe, B., Suh, T., Shinn, K., Lee, C.-W., Lee, C., & Paik, I. (1996) · Investigative Radiology · doi:10.1097/00004424-199606000-00006 · Cited by 83
Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls
Yurgelun-Todd, D. A., Renshaw, P. F., Gruber, S. A., WATERNAUX, C. M., & Cohen, B. M. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00071-2 · Cited by 82
Decreased left frontal lobe N-acetylaspartate in schizophrenia
Deicken, R. F., Zhou, L., Corwin, F. D., Vinogradov, S., & Weiner, M. W. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.688 · Cited by 82
Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia
Jessen, F., Scherk, H., Träber, F., Theyson, S., Berning, J., Tepest, R., Falkai, P., Schild, H. H., Maier, W., Wagner, M., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.011 · Cited by 80
Sigmundsson, T., Maier, M., Toone, B., Williams, S., Simmons, A., Greenwood, K., & Ron, M. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00533-9 · Cited by 78
Bartha, R., Al-Semaan, Y. M., Williamson, P., Drost, D. J., MALLA, A. K., Carr, T. J., Densmore, M., Canaran, G., & Neufeld, R. W. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00007-4 · Cited by 77
Braus, D. F. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00003-2 · Cited by 77
Yoo, S. Y., Yeon, S., Choi, C., Kang, D.-H., Lee, J., Shin, N. Y., Jung, W. H., Choi, J., Jang, D., & Kwon, J. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.036 · Cited by 76
Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect
Heimberg, C., Komoroski, R. A., Lawson, W. B., Cardwell, D. A., & Karson, C. N. (1998) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(98)00034-1 · Cited by 75
Bustillo, J., Rowland, L. M., Jung, R. E., Brooks, W. M., Qualls, C., Hammond, R., Hart, B. L., & Lauriello, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301631 · Cited by 73
Szulc, A., Galińska-Skok, B., Tarasów, E., Dzienis, W., Kubas, B., Konarzewska, B., Walecki, J. M., Alathiaki, A. S., & Czernikiewicz, A. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-873156 · Cited by 72
Working Memory Deficits and Levels of N-Acetylaspartate in Patients With Schizophreniform Disorder
Bertolino, A., Sciota, D., Brudaglio, F., Altamura, M., Blasi, G., Bellomo, A., Antonucci, N., Callicott, J. H., Goldberg, T. E., Scarabino, T., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.483 · Cited by 72
Block, W., Bayer, T. A., Tepest, R., Träber, F., Rietschel, M., Müller, D. J., Schulze, T. G., Honer, W. G., Maier, W., Schild, H. H., et al. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01264-7 · Cited by 71
1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia
Yamasue, H., Fukui, T., Fukuda, R., Yamada, H., Yamasaki, S., Kuroki, N., Abe, O., Kasai, K., Tsujii, K., Iwanami, A., et al. (2002) · Neuroreport · doi:10.1097/00001756-200211150-00029 · Cited by 71
Ohrmann, P., Kugel, H., Bauer, J., Siegmund, A., Kölkebeck, K., Suslow, T., Wiedl, K. H., Rothermundt, M., Arolt, V., & Pedersen, A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.005 · Cited by 70
Bustillo, J., Lauriello, J., Rowland, L. M., Thomson, L., Petropoulos, H., Hammond, R., HART, B., & Brooks, W. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00210-4 · Cited by 70
Weber‐Fahr, W., Ende, G., Braus, D. F., Bachert, P., Soher, B. J., Henn, F. A., & Büchel, C. (2002) · NeuroImage · doi:10.1006/nimg.2002.1057 · Cited by 69
Braus, D. F., Ende, G., Weber‐Fahr, W., Demirakça, T., & Henn, F. A. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-18037 · Cited by 69
Purdon, S. E., Valiakalayil, A., Hanstock, C. C., Seres, P., & Tibbo, P. G. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.028 · Cited by 67
Phillips, L., Yung, A. R., & McGorry, P. D. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00798.x · Cited by 67
Tang, C. Y., Friedman, J. I., Shungu, D. C., Chang, L., Ernst, T., Stewart, D. G., Hajianpour, A., Carpenter, D. M., Ng, J., Mao, X., et al. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-25 · Cited by 67
Choe, B., Kim, K. T., Suh, T. S., Lee, C., Paik, I., Bahk, Y.-W., Shinn, K.-S., & Lenkinski, R. E. (1994) · Academic Radiology · doi:10.1016/s1076-6332(05)80716-0 · Cited by 64
Fannon, D. G., Simmons, A., Tennakoon, L., O’Ceallaigh, S., Sumich, A. L., Doku, V. C. K., Shew, C., & Sharma, T. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00185-9 · Cited by 64
Bustillo, J., Rowland, L. M., Lauriello, J., Petropoulos, H., Hammond, R., Hart, B. L., & Brooks, W. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.130 · Cited by 63
Preliminary study of frontal lobe 1H MR spectroscopy in childhood‐onset schizophrenia
Thomas, M. A., Ke, Y., Levitt, J. G., Caplan, R., Curran, J. G., Asarnow, R. F., & McCracken, J. T. (1998) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880080413 · Cited by 61
Delamillieure, P., Constans, J., Fernandez, J., Brazo, P., Benali, K., Courtheoux, P., Thibaut, F., Petit, M., & Dollfus, S. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006942 · Cited by 61
Prediction of Functional Outcome 18 Months After a First Psychotic Episode
Wood, S. J., Berger, G. E., Lambert, M., Conus, P., Velakoulis, D., Stuart, G. W., Desmond, P. M., McGorry, P. D., & Pantelis, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.9.969 · Cited by 61
Wood, S. J., Yücel, M., Wellard, R. M., Harrison, B. J., Clarke, K., Fornito, A., Velakoulis, D., & Pantelis, C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.008 · Cited by 60
Bustillo, J., Lauriello, J., Rowland, L. M., Jung, R. E., Petropoulos, H., Hart, B. L., Blanchard, J. J., Keith, S. J., & Brooks, W. M. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00102-0 · Cited by 59
Ende, G., Braus, D. F., Walter, S., & Henn, F. A. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1314 · Cited by 57
Wood, S. J., Berger, G. E., Wellard, R. M., Proffitt, T., McConchie, M., Velakoulis, D., McGorry, P. D., & Pantelis, C. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.03.012 · Cited by 56
Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia
Fujimoto, T., Nakano, T., Takano, T., Takeuchi, K., Yamada, K., Fukuzako, T., & Akimoto, H. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00316-9 · Cited by 56
Tanaka, Y., Obata, T., SASSA, T., Yoshitome, E., Asai, Y., Ikehira, H., Suhara, T., Okubo, Y., & Nishikawa, T. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01515.x · Cited by 54
Omori, M., Murata, T., Kimura, H., Koshimoto, Y., Kado, H., Ishimori, Y., Ito, H., & Wada, Y. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(00)00049-4 · Cited by 53
Delamillieure, P., Fernandez, J. Μ., Constans, J., Brazo, P., Benali, K., Abadie, P., Vasse, T., Thibaut, F., Courthè®μx, P., Petit, M., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.641 · Cited by 52
Quantitative Proton-Decoupled 31P MRS of the Schizophrenic Brain In Vivo
Blüml, S., Tan, J., Harris, K. C., ADATIA, N., Karme, A., Sproull, T., & Ross, B. D. (1999) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199903000-00017 · Cited by 51
Galińska-Skok, B., Szulc, A., Tarasów, E., Kubas, B., Dzienis, W., Czernikiewicz, A., & Walecki, J. M. (2009) · PubMed · Cited by 50
Brooks, W. M., Hodde-Vargas, J., Vargas, A., Yeo, R. A., Ford, C. C., & Hendren, R. L. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00462-9 · Cited by 49
Mehler, C., & Warnke, A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200019 · Cited by 48
1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia
O’Neill, J., Levitt, J. G., Caplan, R., Asarnow, R., McCracken, J. T., Toga, A. W., & Alger, J. R. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.11.005 · Cited by 45
Stanley, J. A., Vemulapalli, M., Nutche, J. J., Montrose, D. M., Sweeney, J. A., Pettegrew, J. W., MacMaster, F. P., & Keshavan, M. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.028 · Cited by 44
Shioiri, T., Hamakaw, H., Kato, T., Murashita, J., Fujii, K., Inubushi, T., & Takahashi, S. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)00017-5 · Cited by 44
Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study
Maier, M., & Ron, M. A. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)00044-8 · Cited by 43
Evidence for altered cerebellar vermis neuronal integrity in schizophrenia
Deicken, R. F., Feiwell, R., Schuff, N. W., & Soher, B. J. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00103-2 · Cited by 43
Reduction of the Internal Capsule in Families Affected with Schizophrenia
Wobrock, T., Kamer, T., Roy, A., Vogeley, K. T., Schneider-Axmann, T., Wagner, M., Maier, W., Rietschel, M., Schulze, T. G., Scherk, H., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.026 · Cited by 42
Aydın, K., Üçok, A., & Güler, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.007 · Cited by 41
The neuronal pathology of schizophrenia: molecules and mechanisms
Reynolds, G. P., & Harte, M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350433 · Cited by 40
Shimizu, E., Hashimoto, K., Ochi, S., Fukami, G., Fujisaki, M., KOIKE, K., OKAMURA, N., Ohgake, S., KOIZUMI, H., & Matsuzawa, D. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.015 · Cited by 36
Venkatraman, T. N., Hamer, R. M., Perkins, D. O., Song, A. W., Lieberman, J. A., & Steen, R. G. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1055 · Cited by 35
Szulc, A., Galińska-Skok, B., Tarasów, E., Kubas, B., Dzienis, W., Konarzewska, B., Popławska, R., Tomczak, A. A., Czernikiewicz, A., & Walecki, J. M. (2007) · PubMed · Cited by 35
Tunc‐Skarka, N., Weber‐Fahr, W., Hoerst, M., Meyer‐Lindenberg, A., Zink, M., & Ende, G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.061 · Cited by 34
Multiregional 1 H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia
Ende, G., Braus, D. F., Walter, S., Weber‐Fahr, W., & Henn, F. A. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0398-5 · Cited by 34
Hagino, H., Suzuki, M., Mori, K., Nohara, S., Yamashita, I., Takahashi, T., Kurokawa, K., Matsui, M., Watanabe, N., Seto, H., et al. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.01045.x · Cited by 34
Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis
Lappin, J., Dazzan, P., Morgan, K. D., Morgan, C., Chitnis, X. A., John Suckling, A., Fearon, P., Jones, P. B., Leff, J., Murray, R. M., et al. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.51.s123 · Cited by 34
Giménez, M., Junqué, C., Pérez, M., Vendrell, P., Baeza, I., Salamero, M., Mercader, J. M., & Bernardo, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00698-0 · Cited by 32
Jakary, A., Vinogradov, S., Feiwell, R., & Deicken, R. F. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.012 · Cited by 31
Fukuzako, H., Kodama, S., Fukuzako, T., Yamada, K., Doi, W., Sato, D., & Takigawa, M. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00035-9 · Cited by 30
Zabala, A., Sánchez‐Gonzalez, J., Parellada, M., Moreno, D. M., Reig, S., Burdalo, M. T., Robles, O., Desco, M., & Arango, C. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.12.016 · Cited by 29
Further Evidence for Altered Cerebellar Neuronal Integrity in Schizophrenia
Ende, G., Hubrich-Ungureanu, P., Walter, S., Weber‐Fahr, W., Kämmerer, N., Braus, D. F., & Henn, F. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.790 · Cited by 28
Martínez-Granados, B., Brotons, O., Martínez‐Bisbal, M. C., Celda, B., Martí‐Bonmatí, L., Aguilar, E. J., González, J. C., & Sanjuán, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.025 · Cited by 26
Neuronal Dysfunction of the Frontal Lobe in Schizophrenia
Pae, C., Choe, B., Joo, R.-H., Lim, H. K., Kim, T., Yoo, S., Choi, B.-G., Kim, J.-J., Lee, S.-J., Lee, C., et al. (2004) · Neuropsychobiology · doi:10.1159/000079972 · Cited by 26
Miyaoka, T., Yasukawa, R., Mizuno, S., Sukegawa, T., Inagaki, T., Horiguchi, J., Seno, H., Oda, K., & Kitagaki, H. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.05.003 · Cited by 25
Aydın, K., Ucok, A., & Cakir, S. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0691 · Cited by 25
Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder
Crespo, F. S., Luque, R., Prieto‐Merino, D., Sau, P., Albert, C., Leal, I., de Luxan, A., Osuna, M. I., Ruiz, M., Galán, R., et al. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0808-9 · Cited by 23
Yasukawa, R., Miyaoka, T., Mizuno, S., Inagaki, T., Horiguchi, J., Oda, K., & Kitagaki, H. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0553 · Cited by 22
Ando, K., Takei, N., Matsumoto, H., Iyo, M., Isoda, H., & Mori, N. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00290-0 · Cited by 21
Proton magnetic resonance spectroscopy (1H-MRS) of the thalamus in schizophrenia
Delamillieure, P., Constans, J., Fernandez, J., Brazo, P., & Dollfus, S. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00522-8 · Cited by 20
Proton magnetic resonance spectroscopy of lenticular nuclei in simple schizophrenia
Ohara, K., Isoda, H., Suzuki, Y., Takehara, Y., Ochiai, M., Takeda, H., Hattori, K., Igarashi, Y., & Ohara, K. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00089-0 · Cited by 20
Heritability Heightens Brain Metabolite Differences in Schizophrenia
Fukuzako, H. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.1.95 · Cited by 18
Yamasue, H., Fukui, T., Fukuda, R., Kasai, K., Iwanami, A., Kato, N., & Kato, T. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003687 · Cited by 17
Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia.
Tibbo, P. G., Hanstock, C. C., Asghar, S., Silverstone, P. H., & Allen, P. S. (2000) · PubMed Central · Cited by 17
Başoğlu, C., Çetin, M., Öner, Ö., Ebrinç, S., Semiz, Ü. B., Kandilcioğlu, H., Şilit, E., & Kizilkaya, E. (2006) · PubMed · Cited by 13
SNAP-25 genotype influences NAA/Cho in left hippocampus
Scherk, H., Backens, M., Zill, P., Schneider-Axmann, T., Wobrock, T., Usher, J., Reith, W., Falkai, P., Möller, H., Bondy, B., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0103-y · Cited by 10
Sanches, R. F., Crippa, J. A. S., Hallak, J. E. C., de Sousa, J. P. M., Araújo, D., dos Santos, A. C., & Zuardi, A. W. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008001200015 · Cited by 10
Molina, V., Sanz, J., Sarramea, F., Luque, R., Carlos Benito, C., & Palomo, T. (2006) · Neuropsychobiology · doi:10.1159/000098653 · Cited by 10
Research works printed but not linked: 2
- Venkatraman, 2006, Single-voxel 1H PRESS at 4.0 T: Precision and variability of measurements in anterior cingulate and hippocampus, NMR Biomed, 19, 484, 10.1002/nbm.1055 · DOI
- Steen, 2005, Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and Meta-analysis, Neuropsychopharmacology, 30, 1949, 10.1038/sj.npp.1300850 · DOI · Paper page
Cited by
Sorted by citations
Advances in multimodal data fusion in neuroimaging: Overview, challenges, and novel orientation
Zhang, Y., Dong, Z., Wang, S., Yu, X., Yao, X., Zhou, Q., Hu, H., Li, M., Jiménez-Mesa, C., Ramı́rez, J., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.07.006 · Cited by 461
“Magnetic resonance spectroscopy studies found that the brain metabolism of schizophrenia patients was abnormal [198-200] .”
Developmental timing and critical windows for the treatment of psychiatric disorders
Marín, O. (2016) · Nature Medicine · doi:10.1038/nm.4225 · Cited by 374
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314540297 · Cited by 297
Pillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230
“One meta-analysis examining brain chemistry in FEP was identified [52].”
Neurometabolites in schizophrenia and bipolar disorder — A systematic review and meta-analysis
Kraguljac, N. V., Reid, M. A., White, D. M., Jones, R., den Hollander, J., Lowman, D., & Lahti, A. C. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.02.003 · Cited by 207
Metadata
- Authors
- Brugger, S., Davis, J. M., Leucht, S., & Stone, J. M.
- Affiliations
- St George's, University of London (GB)
- University of Maryland, Baltimore (US)
- Technical University of Munich (DE)
- King's College London (GB)
- Corresponding author
- Stone, James M.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 69
- Issue
- 5
- Pages
- 495-503
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1983956215
- Cited by
- 131
- References
- 133
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 4 · 2020: 9 · 2019: 14 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 14 · 2014: 16 · 2013: 15 · 2012: 17
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Eli Lilly
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, N-acetylaspartate, 1H NMR, disease stage, prodromal schizophrenia, first-episode schizophrenia, chronic schizophrenia, clinical high risk for psychosis, thalamus, frontal lobe, temporal lobe, neuronal integrity, brain metabolites
- MeSH terms
- Aspartic Acid, Data Interpretation, Statistical, Frontal Lobe, Humans, Magnetic Resonance Spectroscopy, Regression Analysis, Risk, Schizophrenia, Schizophrenic Psychology, Temporal Lobe, Thalamus, Publication Bias, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
